|
市場調査レポート
商品コード
1804836
北米のAI支援医療画像市場North America AI-assisted Medical Imaging Market |
||||||
|
|||||||
価格
| 北米のAI支援医療画像市場 |
|
出版日: 2025年09月04日
発行: Marketstrat, Inc.
ページ情報: 英文 54 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
調査範囲
- 国米国、カナダ
- モダリティCT、MRI、X線/DR、超音波、PET/核医学
- 臨床分野腫瘍学、神経学/脳卒中、心臓病学、呼吸器/肺、MSK/整形、一般
- 用途トリアージ→検出→再構成→統合
- 収益の流れハードウェア、ソフトウェア、サービス、クラウド/利用料金制
- 最終用途病院/IDN、画像診断センター、クリニック、遠隔放射線医療、その他.（セクション2、目的と範囲）
調査手法
二重レンズアプローチ：トップダウンはNA合計と国別分割への調整、ボトムアップは工場出荷と後付けの混合、ASPバンド、NA特有のエビデンスウェイト（FDA/Health Canada cadence、償還シグナル、企業購買、RWE）を用いたモダリティ別装着率促進要因。
レポート概要
- 軌跡：北米は2032年までに132億ドルに拡大（CAGR30％）（エグゼクティブサマリー10ページ、表1 14ページ）。
- 装着率のヘッドルーム：OEMのAIは、超音波とPETの両方で、新規CTの20％、新規MRサンプルランウェイの15％に搭載されます。（添付文書料金の考察と図3、pp.18-19.）
数字を動かしているもの
- 診療報酬の引き下げ：CMSのNTAP更新（脳卒中AI）と、CT-FFR、エコー歪み、乳房AIのための新しいCPTスタックのおかげで、米国が引き続き優勢であり、対カナダで約9対1です。
- 企業の購買力：米国の大手IDNは複数年の"AI-store"ライセンスをロックしており、基本的なスキャンの伸びを上回るスピードで支出を拡大しています。
- 規制の明確化：FDAのPredetermined Change-Control Plan草案は、再申請なしでアルゴリズムのアップグレードを可能にし、更新サイクルを短縮し、ARRを向上させます。
- カナダのキャッチアップ：一人払いの州は慎重な動きを見せるが、全国的な肺がん検診のパイロットとCADTH別結核AIのHTAが採用を後押し。CAGRは29%と低いが、それでも市場規模は3年ごとに倍増します。
- 国境を越えたベンダー：米国のクラウドAIプロバイダーは、プライバシーのコンプライアンス（PIPEDA/HIPAA）が証明されれば、カナダの入札を獲得する傾向が強まり、その差はさらに縮まります。
レポートのメリット
- どこで勝負するか/どう勝つかNAGTM成長・成熟度マトリックス、競合データセット、規制速度、M&Aウォッチリスト。（図と表、15-18ページ）。
- 各国のプレイブック：米国とカナダのGTMレーダー、チャネル/価格設定マトリックス、顧客層の潜在的可能性、12ヶ月のアクションキューを含むタイムライン。（米国31～38頁、カナダ52～54頁）。
- 予測の深さ：2032年までの国別、モダリティ別、臨床領域別、用途別、収益源別、最終用途別の内訳。（24-30、43-51ページにわたる表）。
目次
セクション1-エグゼクティブサマリー
セクション2-調査手法
セクション3-北米市場
- 市場サマリー
- 市場規模と促進要因
- 最新動向
- 戦略展望
- 競合環境
- 新たな重点分野
- 北米市場の推定と予測（2023年～2032年）
- Markintel GTM成長・成熟度マトリックス-北米
- 規制の速度-北米
- モダリティ別OEM AIアタッチ率
セクション4-米国市場
- 市場サマリー-米国
- 市場概要-米国
- 人口統計と疫学
- マクロ経済と医療費支出
- イメージングボリュームとインストールベース
- 規制と償還のスナップショット
- ヘルスケア提供と実践パターン
- AI市場力学（イメージング）
- 競合情勢
- ベンダーにとっての教訓
- 米国市場、臨床領域別
- 米国市場、画像診断法別
- 米国市場、収益源別
- 米国市場、臨床用途別
- 米国市場、最終用途組織別
- 米国市場、AI技術別
- Markintel成長成熟度マトリックス-米国およびカナダ
- Markintelソリューション導入および成長マトリックス-米国およびカナダ
- Markintelエコシステムコラボレーションマトリックス-米国およびカナダ
- GTM概要-米国
セクション5-カナダ市場
- 市場サマリー：カナダ
- 市場概要-カナダ
- 臨床分野別カナダ市場
- カナダ市場、臨床領域別
- カナダ市場、画像診断法別
- カナダ市場、収益源別
- カナダ市場、臨床用途別
- カナダ市場、最終用途組織別
- カナダ市場、AI技術別
- GTM概要- カナダ
図表
List of Figures
- Figure 1: Markintel GTM Growth and Maturity Matrix - North America
- Figure 2: Regulatory Velocity - North America
- Figure 3: OEM AI Attach-Rate by Modality - North America
- Figure 4: Factory vs Retrofit - North America
- Figure 5: Markintel Growth Maturity Matrix - US & Canada
- Figure 6: Markintel Solution Adoption & Growth Matrix - US & Canada
- Figure 7: Markintel Ecosystem Collaboration Matrix - US & Canada
- Figure 8: GTM Readiness Radar - US
- Figure 9: Customer Tier Potential - US
- Figure 10: GTM Timeline (2025-2028) - US
- Figure 11: Regulatory x Funding Heatmap - US (2024)
- Figure 12: Dual-Layer Adjacency-Opportunity Radar - US (Post-2026)
- Figure 13: Whitespace Partner-Fit Matrix - US (2024-26)
- Figure 14: GTM Readiness Radar - Canada
- Figure 15: Market Potential by Customer Tier - Canada (2032)
List of Tables
- Figure 1: Markintel GTM Growth and Maturity Matrix - North America
- Figure 2: Regulatory Velocity - North America
- Figure 3: OEM AI Attach-Rate by Modality - North America
- Figure 4: Factory vs Retrofit - North America
- Figure 5: Markintel Growth Maturity Matrix - US & Canada
- Figure 6: Markintel Solution Adoption & Growth Matrix - US & Canada
- Figure 7: Markintel Ecosystem Collaboration Matrix - US & Canada
- Figure 8: GTM Readiness Radar - US
- Figure 9: Customer Tier Potential - US
- Figure 10: GTM Timeline (2025-2028) - US
- Figure 11: Regulatory x Funding Heatmap - US (2024)
- Figure 12: Dual-Layer Adjacency-Opportunity Radar - US (Post-2026)
- Figure 13: Whitespace Partner-Fit Matrix - US (2024-26)
- Figure 14: GTM Readiness Radar - Canada
- Figure 15: Market Potential by Customer Tier - Canada (2032)
目次
Product Code: MINTP-M01120
Report Scope
- Countries: United States, Canada
- Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
- Clinical Areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General
- Applications: Triage -> detection -> reconstruction -> integration
- Revenue Streams: Hardware, Software, Services, Cloud/Pay per Use
- End use: Hospitals/IDNs, Imaging Centers, Clinics, Teleradiology, Other. (Section 2, Objective & Scope.)
Methodology
Dual lens approach: top down reconciliation to NA totals and country splits; bottom up attach rate engine by modality with factory vs retrofit mixes, ASP bands, and NA specific evidence weights (FDA/Health Canada cadence, reimbursement signals, enterprise buying, and RWE).
Report Snapshot
- Trajectory: North America expands to ~US$13.2B by 2032 (~30% CAGR) . (Executive Summary, p.10; Table 1, p.14.)
- Attach rate headroom: OEM AI ships on ~20% of new CT and ~15% of new MR-ample runway across ultrasound and PET. (Attach rate discussion & Figure 3, pp.18-19.)
What's Driving the Numbers
- Reimbursement pull: The U.S. continues to dominate-about 9-to-1 versus Canada-thanks to CMS NTAP renewals (stroke AI) and the emerging CPT stack for CT-FFR, echo strain and breast-AI.
- Enterprise buying power: Large U.S. IDNs lock multi-year "AI-store" licenses, scaling spend faster than underlying scan growth.
- Regulatory clarity: FDA's Predetermined Change-Control Plan draft allows algorithm upgrades without re-filing, shortening refresh cycles and feeding ARR.
- Canada's catch-up: Single-payer provinces move more cautiously, but national lung-cancer screening pilots and CADTH's positive HTA for TB AI push adoption. The lower 29 % CAGR still doubles market size every three years.
- Cross-border vendors: U.S. cloud-AI providers increasingly win Canadian tenders once privacy compliance (PIPEDA/HIPAA) is proven, further narrowing the gap.
Report Benefits
- Where to play / how to win: NA GTM Growth & Maturity Matrix, competitive dataset, regulatory velocity, and M&A watchlist. (Figures & tables, pp.15-18.)
- Country playbooks: U.S. & Canada GTM radars, channel/pricing matrices, customer tier potential, and timelines with 12 month action cues. (U.S. pp.31-38; Canada pp.52-54.)
- Forecast depth: Breakouts by country, modality, clinical area, application, revenue stream, and end use through 2032. (Tables across pp.24-30, 43-51.)
TABLE OF CONTENTS
SECTION 1 - EXECUTIVE SUMMARY
- 25 second Read
- Size & Trajectory
- Modality & Attach rate Dynamics
- Buyer & Route to Market
- Competitive Temperature
- What to do in the Next 12 Months
SECTION 2 - RESEARCH METHODOLOGY
- Objective & Scope
- Dual lens Architecture
- North America-specific Evidence Stack & Weights
- Calibration Choices (NA)
SECTION 3 - NORTH AMERICAN MARKET
- Market Summary
- Market Size & Drivers
- Latest Trends
- Strategic Outlook
- Competitive Environment
- New Focus Areas
- North American Market Estimates & Forecasts (2023-2032)
- AI Imaging Market by Country - North America
- What's Driving the Numbers
- Implications
- Markintel GTM Growth and Maturity Matrix - North America
- Competitive Dataset - North America
- Competitive Context - North America AI-Imaging 2024
- Strategic Takeaways
- Growth & Maturity Highlights - North America
- M&A Watchlist - North America Rising Stars
- Regulatory Velocity - North America
- OEM AI Attach-Rate by Modality
- Attach Rate Trends - North America
- Factory vs Retrofit - North America
SECTION 4 - UNITED STATES MARKET
- Market Summary - United States
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview - United States
- Demographics & Epidemiology
- Macro economics & Health Spending
- Imaging Volume & Installed Base
- Regulatory & Reimbursement Snapshot
- Healthcare Delivery & Practice Patterns
- AI Market Dynamics (Imaging)
- Competitive Landscape
- Takeaways for Vendors
- US Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- U.S. AI-Imaging Outlook by Clinical Area (2023 -> 2032)
- Key Dynamics to Watch
- Implications for Vendors
- US Market by Imaging Modality
- Forecast by Modality (2023-2032, USD Mill)
- U.S. Modality Outlook: Who Grows, Who Overtakes
- Key Takeaways
- US Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- U.S. Revenue Stream Shift: From Capital Boxes to Recurring Bytes
- What's Driving the Mix Change
- Implications for Vendors
- US Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook by Clinical Application
- Highlights
- Implications
- US Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Who Buys AI-and How That Mix Shifts Through 2032
- What's Behind the Shift
- Strategic Implications for Vendors
- US Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Outlook by Core Technology (2023-2032)
- Markintel Growth Maturity Matrix - US & Canada
- Competitive Dataset - United States
- Competitive Context - U.S./North America
- What to Watch Next
- Markintel Solution Adoption & Growth Matrix - US & Canada
- Scorecard - Solution Adoption & Growth Matrix (U.S. & Canada)
- Strategic Implications for Stakeholders
- Markintel Ecosystem Collaboration Matrix - US & Canada
- Who to Partner with and How Deep?
- What Succeess Looks Like in Each Quadrant
- Stratregic Guidance
- GTM at a Glance - United States
- Channel & Pricing Matrix
- GTM Readiness Radar - US
- Customer Tier Potential - US
- GTM Timeline (2025-2028) - US
- Fast Strategic Cues (2025)
- Regulatory x Funding Heatmap - US
- Adjacency-Opportunity Radar - US
- Whitespace Partner-Fit Matrix - US
SECTION 5 - CANADIAN MARKET
- Market Summary: Canada
- Key Market Dynamics
- Strategic Takeaways
- Top 3 Recommendations
- Market Overview - Canada
- Demographics & Epidemiology
- Imaging Supply & Utilization
- Health System & Practice Patterns
- Regulatory & Reimbursement
- AI-Imaging Market Dynamics
- Competitive Snapshot
- Key Implications
- Canadian Market by Clinical Area
- Forecast by Clinical Area (2023-2032, USD Mill)
- Outlook by Clinical Area
- Key Dynamics to Watch
- Implications for Vendors
- Canadian Market by Imaging Modality
- Forecast by Imaging Modality (2023-2032, USD Mill)
- Outlook by Modality
- Key Dynamics to Watch (2025-27)
- Implications for Vendors
- Canadian Market by Revenue Stream
- Forecast by Revenue Stream (2023-2032, USD Mill)
- What's Driving Each Revenue Stream
- Key Dynamics to Watch
- Implications for Vendors
- Canadian Market by Clinical Application
- Forecast by Clinical Application (2023-2032, USD Mill)
- Outlook & Drivers by Application
- Key Market Dynamics to 2027
- Implications for Vendors and Providers
- Canadian Market by End-Use Organization
- Forecast by End-Use Organization (2023-2032, USD Mill)
- Outlook 2025-2032
- Key Drivers by Segment
- Implications for Vendors
- Strategic Takeaways
- Canadian Market by AI Technology
- Forecast by AI Technology (2023-2032, USD Mill)
- Highlights by Technology
- Key Dynamics to Watch (2025 27)
- Implications for Vendors & Providers
- GTM at a Glance - Canada
- GTM Readiness Radar - Canada
- Tiered Customer Landscape
- Channel & Pricing Matrix
- GTM Timeline (Canada)
- Fast Cues for 2025 Stakeholders
